Recombinant IL23A (Mirikizumab Biosimilar) antibody
The Mammalian Cells Monoclonal anti-IL23A (Mirikizumab Biosimilar) antibody has been validated for ELISA. It is suitable to detect IL23A (Mirikizumab Biosimilar) in samples from Human.
Catalog No. ABIN7488152
$336.06
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 8 Business Days
Quick Overview for Recombinant IL23A (Mirikizumab Biosimilar) antibody (ABIN7488152)
Target
IL23A (Mirikizumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Mammalian Cells
Clonality
Monoclonal
Conjugate
This IL23A (Mirikizumab Biosimilar) antibody is un-conjugated
Application
ELISA
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Mirikizumab Biosimilar - Anti-IL23A mAb
-
Characteristics
- Antibody Type: IgG4-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Isotype
- IgG4 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS pH 7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- IL23A (Mirikizumab Biosimilar)
-
Target Type
- Biosimilar
-
Background
-
LY-3074828
Mirikizumab is a humanized IgG4 monoclonal antibody that targets p19 subunit of IL-23. Currently, mirikizumab is being developed for a variety of immune diseases, including psoriasis, UC, and Crohn's disease (CD). -
CAS-No
- 1884201-71-1
Target
-
You are here:
